Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

Articles published in
J Virol
    June 2024
  1. DAVID SC, Schaub A, Terrettaz C, Motos G, et al
    Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
    J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
    >> Share

    May 2024
  2. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    Correction for Huang et al., "N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies".
    J Virol. 2024 May 31:e0112823. doi: 10.1128/jvi.01128.
    >> Share

  3. CARTER DM, Darby CA, Lefoley BC, Crevar CJ, et al
    Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses".
    J Virol. 2024 May 31:e0181323. doi: 10.1128/jvi.01813.
    >> Share

  4. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Retraction for Carter et al., "Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses".
    J Virol. 2024 May 31:e0183223. doi: 10.1128/jvi.01832.
    >> Share

  5. MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
    A community science approach to public health and public trust in science.
    J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
    >> Share

  6. KNOLL M, Honce R, Meliopoulos V, Segredo-Otero EA, et al
    Host obesity impacts genetic variation in influenza A viral populations.
    J Virol. 2024 May 24:e0177823. doi: 10.1128/jvi.01778.
    >> Share

  7. SCHWAB LSU, Do THT, Pilapitiya D, Koutsakos M, et al
    Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response.
    J Virol. 2024 May 23:e0160423. doi: 10.1128/jvi.01604.
    >> Share

  8. MA MT, Jiang Q, Chen C-H, Badeti S, et al
    S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
    J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
    >> Share

  9. MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
    Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City.
    J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
    >> Share

  10. CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al
    Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro) main protease (Mpro) from proteomic identification of P6-P6' active site specificity.
    J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049.
    >> Share

  11. YU M, Li J, Gao W, Li Z, et al
    Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
    >> Share

    April 2024
  12. VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al
    Harnessing the power of IFN for therapeutic approaches to COVID-19.
    J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204.
    >> Share

  13. MAO D, Liu S, Phan AT, Renner S, et al
    The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.
    J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347.
    >> Share

  14. HAN Y, Yuan Z, Yi Z
    Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
    J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
    >> Share

  15. BOUGON J, Kadijk E, Gallot-Lavallee L, Curtis BA, et al
    Influenza A virus NS1 effector domain is required for PA-X-mediated host shutoff in infected cells.
    J Virol. 2024 Apr 17:e0190123. doi: 10.1128/jvi.01901.
    >> Share

  16. PEREZ DR
    A devastating blow: personal reflections on Argentina's scientific decline.
    J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
    >> Share

  17. ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
    Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
    J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
    >> Share

  18. TAKADA K, Orba Y, Kida Y, Wu J, et al
    Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
    J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
    >> Share

  19. BU H, Zhang S, Li P, Liu Z, et al
    Secreted phospholipase PLA2G2E contributes to regulation of T cell immune response against influenza virus infection.
    J Virol. 2024 Apr 9:e0019824. doi: 10.1128/jvi.00198.
    >> Share

  20. BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
    Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
    J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
    >> Share

  21. YANG R, Han P, Han P, Li D, et al
    Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
    J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
    >> Share

  22. XIAO X, Fu Y, You W, Huang C, et al
    Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
    >> Share

  23. MAES A, Botzki A, Mathys J, Impens F, et al
    Systematic review and meta-analysis of genome-wide pooled CRISPR screens to identify host factors involved in influenza A virus infection.
    J Virol. 2024 Apr 3:e0185723. doi: 10.1128/jvi.01857.
    >> Share

  24. SILVA F, Boal-Carvalho I, Williams N, Chabert M, et al
    Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3.
    J Virol. 2024 Apr 3:e0041124. doi: 10.1128/jvi.00411.
    >> Share

  25. KEOWN J, Baazaoui A, Sebesta M, Stefl R, et al
    Structural and functional characterization of the interaction between the influenza A virus RNA polymerase and the CTD of host RNA polymerase II.
    J Virol. 2024 Apr 2:e0013824. doi: 10.1128/jvi.00138.
    >> Share

  26. BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
    J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
    >> Share

  27. NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
    J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
    >> Share

    March 2024
  28. MAI F, Bergmann W, Reisinger EC, Muller-Hilke B, et al
    The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection.
    J Virol. 2024 Mar 19:e0191223. doi: 10.1128/jvi.01912.
    >> Share

  29. BABOT M, Boulard Y, Agouda S, Pieri L, et al
    Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.
    J Virol. 2024 Mar 14:e0157523. doi: 10.1128/jvi.01575.
    >> Share

  30. SPRUIT CM, Palme DI, Li T, Rios Carrasco M, et al
    Complex N-glycans are important for interspecies transmission of H7 influenza A viruses.
    J Virol. 2024 Mar 12:e0194123. doi: 10.1128/jvi.01941.
    >> Share

  31. HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al
    ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
    J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102.
    >> Share

  32. WEN F, Yan Z, Chen G, Chen Y, et al
    Recent H9N2 avian influenza virus lost hemagglutination activity due to a K141N substitution in hemagglutinin.
    J Virol. 2024 Mar 11:e0024824. doi: 10.1128/jvi.00248.
    >> Share

  33. ZHENG T, Shen B, Bai Y, Li E, et al
    The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
    J Virol. 2024 Mar 6:e0156523. doi: 10.1128/jvi.01565.
    >> Share

    February 2024
  34. ZHANG M, Liu M, Chen H, Qiu T, et al
    PB2 residue 473 contributes to the mammalian virulence of H7N9 avian influenza virus by modulating viral polymerase activity via ANP32A.
    J Virol. 2024 Feb 29:e0194423. doi: 10.1128/jvi.01944.
    >> Share

  35. MARTINS M, Nooruzzaman M, Cunningham JL, Ye C, et al
    The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
    J Virol. 2024 Feb 29:e0190223. doi: 10.1128/jvi.01902.
    >> Share

  36. HAN J, Chang W, Fang J, Hou X, et al
    The H9N2 avian influenza virus increases APEC adhesion to oviduct epithelia by viral NS1 protein-mediated activation of the TGF-beta pathway.
    J Virol. 2024 Feb 28:e0151223. doi: 10.1128/jvi.01512.
    >> Share

  37. UPRETY T, Yu J, Nogales A, Naveed A, et al
    Influenza D virus utilizes both 9-O-acetylated N-acetylneuraminic and 9-O-acetylated N-glycolylneuraminic acids as functional entry receptors.
    J Virol. 2024 Feb 20:e0004224. doi: 10.1128/jvi.00042.
    >> Share

  38. NIE L, Huang Y, Cheng Z, Luo H, et al
    An intranasal influenza virus vector vaccine protects against Helicobacter pylori in mice.
    J Virol. 2024 Feb 15:e0192323. doi: 10.1128/jvi.01923.
    >> Share

  39. ZENG J, Du F, Xiao L, Sun H, et al
    Spatiotemporal genotype replacement of H5N8 avian influenza viruses contributed to H5N1 emergence in 2021/2022 panzootic.
    J Virol. 2024 Feb 15:e0140123. doi: 10.1128/jvi.01401.
    >> Share

  40. THOMAS MN, Zanella GC, Cowan B, Caceres CJ, et al
    Nucleoprotein reassortment enhanced transmissibility of H3 1990.4.a clade influenza A virus in swine.
    J Virol. 2024 Feb 14:e0170323. doi: 10.1128/jvi.01703.
    >> Share

  41. KATAYAMA M, Murakami S, Ishida H, Matsugo H, et al
    Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein among influenza D virus lineages revealed using epitope mapping.
    J Virol. 2024 Feb 12:e0190823. doi: 10.1128/jvi.01908.
    >> Share

  42. VANSLAMBROUCK JM, Neil JA, Rudraraju R, Mah S, et al
    Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.
    J Virol. 2024 Feb 9:e0180223. doi: 10.1128/jvi.01802.
    >> Share

  43. SHINGAI M, Iida S, Kawai N, Kawahara M, et al
    Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire.
    J Virol. 2024 Feb 7:e0199523. doi: 10.1128/jvi.01995.
    >> Share

  44. YANG Q, Barbachano-Guerrero A, Fairchild LM, Rowland TJ, et al
    Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a high-fidelity cellular model for investigating HIV-1, dengue, and influenza viruses.
    J Virol. 2024 Feb 7:e0156323. doi: 10.1128/jvi.01563.
    >> Share

  45. LI H, Sun H, Tao M, Han Q, et al
    Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.
    J Virol. 2024 Feb 2:e0112923. doi: 10.1128/jvi.01129.
    >> Share

  46. NIU S, Zhao Z, Liu Z, Rong X, et al
    Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
    J Virol. 2024 Feb 2:e0115723. doi: 10.1128/jvi.01157.
    >> Share

  47. BRICKER TL, Joshi A, Soudani N, Scheaffer SM, et al
    Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
    J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206.
    >> Share

  48. HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al
    SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
    J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546.
    >> Share

    January 2024
  49. ROWE T, Davis W, Wentworth DE, Ross T, et al
    Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells.
    J Virol. 2024 Jan 31:e0149423. doi: 10.1128/jvi.01494.
    >> Share

  50. SHEN S, Guo H, Li Y, Zhang L, et al
    SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.
    J Virol. 2024 Jan 30:e0190923. doi: 10.1128/jvi.01909.
    >> Share

  51. KIERAN TJ, Sun X, Maines TR, Beauchemin CAA, et al
    Exploring associations between viral titer measurements and disease outcomes in ferrets inoculated with 125 contemporary influenza A viruses.
    J Virol. 2024 Jan 19:e0166123. doi: 10.1128/jvi.01661.
    >> Share

  52. DULIN H, Barre RS, Xu D, Neal A, et al
    Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
    J Virol. 2024 Jan 11:e0157123. doi: 10.1128/jvi.01571.
    >> Share

  53. HE Y, Guo Z, Subiaur S, Benegal A, et al
    Antibody inhibition of influenza A virus assembly and release.
    J Virol. 2024 Jan 5:e0139823. doi: 10.1128/jvi.01398.
    >> Share

  54. DEY S, Mondal A
    Unveiling the role of host kinases at different steps of influenza A virus life cycle.
    J Virol. 2024 Jan 4:e0119223. doi: 10.1128/jvi.01192.
    >> Share

  55. FARJO M, Koelle K, Martin MA, Gibson LL, et al
    Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection.
    J Virol. 2024 Jan 4:e0161823. doi: 10.1128/jvi.01618.
    >> Share

  56. LI K, Verma A, Li P, Ortiz ME, et al
    Adaptation of SARS-CoV-2 to ACE2(H353K) mice reveals new spike residues that drive mouse infection.
    J Virol. 2024 Jan 3:e0151023. doi: 10.1128/jvi.01510.
    >> Share

  57. RASMUSSEN AL, Gronvall GK, Lowen AC, Goodrum F, et al
    Virology-the path forward.
    J Virol. 2024 Jan 3:e0179123. doi: 10.1128/jvi.01791.
    >> Share

    December 2023
  58. BOLLAND W, Michel V, Planas D, Hubert M, et al
    High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.
    J Virol. 2023 Dec 13:e0135123. doi: 10.1128/jvi.01351.
    >> Share

  59. JERONIMO PMC, Aksenen CF, Duarte IO, Lins RD, et al
    Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus fitness and adaptation.
    J Virol. 2023 Dec 13:e0140423. doi: 10.1128/jvi.01404.
    >> Share

  60. ZHANG L, Shao Y, Wang Y, Yang Q, et al
    Twenty natural amino acid substitution screening at the last residue 121 of influenza A virus NS2 protein reveals the critical role of NS2 in promoting virus genome replication by coordinating with viral polymerase.
    J Virol. 2023 Dec 6:e0116623. doi: 10.1128/jvi.01166.
    >> Share

  61. PHAM TX, Huynh TTX, Choi J, Lee J-B, et al
    SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19.
    J Virol. 2023 Dec 5:e0173723. doi: 10.1128/jvi.01737.
    >> Share

  62. ZAYOU L, Prakash S, Dhanushkodi NR, Quadiri A, et al
    A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4(+) and CD8(+) T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection.
    J Virol. 2023 Dec 1:e0109623. doi: 10.1128/jvi.01096.
    >> Share

    November 2023
  63. LI K, Huntwork RHC, Horn GQ, Abraha M, et al
    Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
    J Virol. 2023 Nov 29:e0107023. doi: 10.1128/jvi.01070.
    >> Share

  64. DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al
    Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.
    J Virol. 2023 Nov 21:e0151123. doi: 10.1128/jvi.01511.
    >> Share

  65. BRAGAZZI CUNHA J, Leix K, Sherman EJ, Mirabelli C, et al
    Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection.
    J Virol. 2023 Nov 17:e0127623. doi: 10.1128/jvi.01276.
    >> Share

  66. ALRUWAILI M, Armstrong S, Prince T, Erdmann M, et al
    SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption.
    J Virol. 2023 Nov 6:e0042423. doi: 10.1128/jvi.00424.
    >> Share

  67. SUN W, Xu J, Wang Z, Li D, et al
    Clade 2.3.4.4 H5 chimeric cold-adapted attenuated influenza vaccines induced cross-reactive protection in mice and ferrets.
    J Virol. 2023 Nov 2:e0110123. doi: 10.1128/jvi.01101.
    >> Share

  68. RIJNINK WF, Stadlbauer D, Puente-Massaguer E, Okba NMA, et al
    Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.
    J Virol. 2023 Nov 2:e0164622. doi: 10.1128/jvi.01646.
    >> Share

    October 2023
  69. PAHMEIER F, Lavacca T-M, Goellner S, Neufeldt CJ, et al
    Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis.
    J Virol. 2023 Oct 31:e0087823. doi: 10.1128/jvi.00878.
    >> Share

  70. CAO J, Shi M, Zhu L, Li X, et al
    The matrix protein of respiratory syncytial virus suppresses interferon signaling via RACK1 association.
    J Virol. 2023;97:e0074723.
    >> Share

  71. BARTSCH YC, Cizmeci D, Yuan D, Mehta N, et al
    Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine.
    J Virol. 2023 Oct 30:e0077123. doi: 10.1128/jvi.00771.
    >> Share

  72. LI Y, Arcos S, Sabsay KR, Te Velthuis AJW, et al
    Deep mutational scanning reveals the functional constraints and evolutionary potential of the influenza A virus PB1 protein.
    J Virol. 2023 Oct 26:e0132923. doi: 10.1128/jvi.01329.
    >> Share

  73. YAN Z, Li Y, Huang S, Wen F, et al
    Global distribution, receptor binding, and cross-species transmission of H6 influenza viruses: risks and implications for humans.
    J Virol. 2023 Oct 25:e0137023. doi: 10.1128/jvi.01370.
    >> Share

  74. UNDI RB, Ahsan N, Larabee JL, Darlene-Reuter N, et al
    Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle restores cell signaling network.
    J Virol. 2023 Oct 20:e0119423. doi: 10.1128/jvi.01194.
    >> Share

  75. KUMAR S, Delipan R, Chakraborty D, Kanjo K, et al
    Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity.
    J Virol. 2023 Oct 20:e0092223. doi: 10.1128/jvi.00922.
    >> Share

  76. YE G, Pan R, Bu F, Zheng J, et al
    Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
    J Virol. 2023 Oct 19:e0144823. doi: 10.1128/jvi.01448.
    >> Share

  77. SUN H, Wang Y, Chen X, Jiang Y, et al
    Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant.
    J Virol. 2023 Oct 19:e0113723. doi: 10.1128/jvi.01137.
    >> Share

  78. JOHNSON RM, Ardanuy J, Hammond H, Logue J, et al
    Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2.
    J Virol. 2023 Oct 17:e0133623. doi: 10.1128/jvi.01336.
    >> Share

  79. LIANG CY, Huang I, Han J, Sownthirarajan B, et al
    Avian influenza A viruses exhibit plasticity in sialylglycoconjugate receptor usage in human lung cells.
    J Virol. 2023 Oct 16:e0090623. doi: 10.1128/jvi.00906.
    >> Share

  80. WU Y, Shi J, He X, Lu J, et al
    Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.
    J Virol. 2023 Oct 16:e0127923. doi: 10.1128/jvi.01279.
    >> Share

  81. MISPLON JA, Lo CY, Crabbs TA, Price GE, et al
    Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination.
    J Virol. 2023 Oct 13:e0067423. doi: 10.1128/jvi.00674.
    >> Share

  82. MIURA K, Suzuki Y, Ishida K, Arakawa M, et al
    Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells.
    J Virol. 2023 Oct 13:e0042623. doi: 10.1128/jvi.00426.
    >> Share

  83. MAHE D, Bourgeau S, da Silva J, Schlederer J, et al
    SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo.
    J Virol. 2023 Oct 13:e0110423. doi: 10.1128/jvi.01104.
    >> Share

  84. RIBO-MOLINA P, Weiss HJ, Susma B, van Nieuwkoop S, et al
    4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1.
    J Virol. 2023 Oct 12:e0132523. doi: 10.1128/jvi.01325.
    >> Share

  85. ISELI AN, Pohl MO, Glas I, Gaggioli E, et al
    The neuraminidase activity of influenza A virus determines the strain-specific sensitivity to neutralization by respiratory mucus.
    J Virol. 2023 Oct 11:e0127123. doi: 10.1128/jvi.01271.
    >> Share

  86. GIRARD J, Jakob C, Toews LK, Fuchs J, et al
    Disruption of influenza virus packaging signals results in various misassembled genome complexes.
    J Virol. 2023 Oct 9:e0107623. doi: 10.1128/jvi.01076.
    >> Share

  87. CARNACCINI S, Caceres CJ, Gay LC, Ferreri LM, et al
    Antigenic mapping of the hemagglutinin of the H9 subtype influenza A viruses using sera from Japanese quail (Coturnix c. japonica).
    J Virol. 2023 Oct 6:e0074323. doi: 10.1128/jvi.00743.
    >> Share

  88. MCMAHON M, Tan J, O'Dell G, Kirkpatrick Roubidoux E, et al
    Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.
    J Virol. 2023 Oct 6:e0105723. doi: 10.1128/jvi.01057.
    >> Share

  89. KIMURA I, Yamasoba D, Nasser H, Ito H, et al
    Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
    J Virol. 2023 Oct 5:e0101123. doi: 10.1128/jvi.01011.
    >> Share

  90. MENG X, Veit M
    Palmitoylation of the hemagglutinin of influenza B virus by ER-localized DHHC enzymes 1, 2, 4, and 6 is required for efficient virus replication.
    J Virol. 2023 Oct 4:e0124523. doi: 10.1128/jvi.01245.
    >> Share

    September 2023
  91. ZHAO Y, Sui L, Wu P, Li L, et al
    EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8.
    J Virol. 2023 Sep 29:e0102823. doi: 10.1128/jvi.01028.
    >> Share

  92. LI J, Gui Q, Liang FX, Sall J, et al
    The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication.
    J Virol. 2023 Sep 28:e0050723. doi: 10.1128/jvi.00507.
    >> Share

  93. NENNA R, Stern DA, Carr TF, Spangenberg A, et al
    Prenatal exposure to RSV season influences first-year risk of RSV lower respiratory illness and RSV-specific immune responses assessed at birth.
    J Virol. 2023;97:e0076723.
    >> Share

  94. WALLACE LE, de Vries E, van Kuppeveld FJM, de Haan CAM, et al
    Neuraminidase-dependent entry of influenza A virus is determined by hemagglutinin receptor-binding specificity.
    J Virol. 2023 Sep 27:e0060223. doi: 10.1128/jvi.00602.
    >> Share

  95. MCCOOL RS, Musayev M, Bush SM, Derrien-Colemyn A, et al
    Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope.
    J Virol. 2023 Sep 22:e0092923. doi: 10.1128/jvi.00929.
    >> Share

  96. SCHOEN A, Holzer M, Muller MA, Wallerang KB, et al
    Functional comparisons of the virus sensor RIG-I from humans, the microbat Myotis daubentonii, and the megabat Rousettus aegyptiacus, and their response to SARS-CoV-2 infection.
    J Virol. 2023 Sep 20:e0020523. doi: 10.1128/jvi.00205.
    >> Share

  97. FUJITA S, Kosugi Y, Kimura I, Tokunaga K, et al
    Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2.
    J Virol. 2023 Sep 19:e0099023. doi: 10.1128/jvi.00990.
    >> Share

  98. XING M, Wang Y, Wang X, Liu J, et al
    Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants.
    J Virol. 2023 Sep 14:e0072423. doi: 10.1128/jvi.00724.
    >> Share

  99. CASE JB, Scheaffer SM, Darling TL, Bricker TL, et al
    Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    J Virol. 2023 Sep 7:e0062823. doi: 10.1128/jvi.00628.
    >> Share

    August 2023
  100. LIN HF, Liu MQ, Jiang RD, Gong QC, et al
    Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus.
    J Virol. 2023 Aug 21:e0079023. doi: 10.1128/jvi.00790.
    >> Share

  101. LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al
    A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
    J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597.
    >> Share

  102. JIN H, Cheng L, Gong Y, Zhu Y, et al
    Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
    J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192.
    >> Share

  103. ZHANG W, Shi K, Geng Q, Herbst M, et al
    Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
    J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822.
    >> Share

  104. LLEWELLYN GN, Chen HY, Rogers GL, Huang X, et al
    Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.
    J Virol. 2023 Aug 9:e0068423. doi: 10.1128/jvi.00684.
    >> Share

  105. MYKYTYN AZ, Breugem TI, Geurts MH, Beumer J, et al
    SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
    J Virol. 2023 Aug 9:e0085123. doi: 10.1128/jvi.00851.
    >> Share

  106. THOMPSON D, Cismaru CV, Rougier JS, Schwemmle M, et al
    The M2 proteins of bat influenza A viruses reveal atypical features compared to conventional M2 proteins.
    J Virol. 2023 Aug 4:e0038823. doi: 10.1128/jvi.00388.
    >> Share

    July 2023
  107. TALUKDAR SN, McGregor B, Osan JK, Hur J, et al
    Respiratory Syncytial Virus Infection Does Not Induce Epithelial-Mesenchymal Transition.
    J Virol. 2023;97:e0039423.
    >> Share

  108. HICKERSON BT, Petrovskaya SN, Dickensheets H, Donnelly RP, et al
    Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
    J Virol. 2023 Jul 5:e0015423. doi: 10.1128/jvi.00154.
    >> Share

  109. JENSEN JL, Sankhala RS, Dussupt V, Bai H, et al
    Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
    J Virol. 2023 Jul 3:e0159622. doi: 10.1128/jvi.01596.
    >> Share

    June 2023
  110. HUANG J, Chen Z, Ye Y, Shao Y, et al
    DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1.
    J Virol. 2023;97:e0068723.
    >> Share

  111. YANG X, Duan H, Liu X, Zhang X, et al
    Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
    J Virol. 2023 Jun 27:e0061023. doi: 10.1128/jvi.00610.
    >> Share

  112. TERASAKI K, Narayanan K, Makino S
    Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
    J Virol. 2023 Jun 27:e0065923. doi: 10.1128/jvi.00659.
    >> Share

  113. LI A, Zhang B, Zhao K, Yin Z, et al
    SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
    J Virol. 2023 Jun 22:e0051223. doi: 10.1128/jvi.00512.
    >> Share

  114. GOFFIN E, Du X, Hemmi S, Machiels B, et al
    A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
    J Virol. 2023 Jun 20:e0013523. doi: 10.1128/jvi.00135.
    >> Share

  115. CHEN P, Jin Z, Peng L, Zheng Z, et al
    Characterization of an Emergent Chicken H3N8 Influenza Virus in Southern China: a Potential Threat to Public Health.
    J Virol. 2023 Jun 8:e0043423. doi: 10.1128/jvi.00434.
    >> Share

  116. ZHENG H, Ma L, Gui R, Lin X, et al
    Correction for Zheng et al., "G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2".
    J Virol. 2023 Jun 6:e0054623. doi: 10.1128/jvi.00546.
    >> Share

    May 2023
  117. WANG C, Honce R, Salvatore M, Chow D, et al
    Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation and Reduces the Inflammatory Response in Mice.
    J Virol. 2023 May 31:e0049323. doi: 10.1128/jvi.00493.
    >> Share

  118. RUNSTADLER JA, Lowen AC, Kayali G, Tompkins SM, et al
    Field Research Is Essential to Counter Virological Threats.
    J Virol. 2023;97:e0054423.
    >> Share

  119. REZENDE W, Ye X, Angelo LS, Carisey AF, et al
    The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent.
    J Virol. 2023;97:e0025423.
    >> Share

  120. SREENIVASAN CC, Liu R, Gao R, Guo Y, et al
    Influenza C and D Viruses Demonstrated a Differential Respiratory Tissue Tropism in a Comparative Pathogenesis Study in Guinea Pigs.
    J Virol. 2023 May 18:e0035623. doi: 10.1128/jvi.00356.
    >> Share

  121. JIANG H, Joshi A, Gan T, Janowski AB, et al
    The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
    J Virol. 2023 May 18:e0063523. doi: 10.1128/jvi.00635.
    >> Share

  122. SLANINA H, Madhugiri R, Wenk K, Reinke T, et al
    Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
    J Virol. 2023 May 18:e0046523. doi: 10.1128/jvi.00465.
    >> Share

  123. ISHIMARU H, Nishimura M, Tjan LH, Sutandhio S, et al
    Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.
    J Virol. 2023 May 16:e0028623. doi: 10.1128/jvi.00286.
    >> Share

  124. ZHANG L, Wang Y, Shao Y, Guo J, et al
    Fine Regulation of Influenza Virus RNA Transcription and Replication by Stoichiometric Changes in Viral NS1 and NS2 Proteins.
    J Virol. 2023 May 11:e0033723. doi: 10.1128/jvi.00337.
    >> Share

  125. SENGAR A, Cervantes M, Bondalapati ST, Hess T, et al
    Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
    J Virol. 2023 May 3:e0199222. doi: 10.1128/jvi.01992.
    >> Share

    April 2023
  126. SPECK P, Mackenzie J, Bull RA, Slobedman B, et al
    Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
    J Virol. 2023 Apr 25:e0045123. doi: 10.1128/jvi.00451.
    >> Share

  127. PEACOCK TP, Sheppard CM, Lister MG, Staller E, et al
    Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus.
    J Virol. 2023 Apr 19:e0021323. doi: 10.1128/jvi.00213.
    >> Share

  128. KETTUNEN P, Lesnikova A, Rasanen N, Ojha R, et al
    SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
    J Virol. 2023 Apr 11:e0014423. doi: 10.1128/jvi.00144.
    >> Share

  129. LIN SJ, Lin KM, Chen SJ, Ku CC, et al
    Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating Factor Receptor Expression.
    J Virol. 2023 Apr 6:e0010223. doi: 10.1128/jvi.00102.
    >> Share

    March 2023
  130. TAN Y, Shilts MH, Rosas-Salazar C, Puri V, et al
    Influence of Sex on Respiratory Syncytial Virus Genotype Infection Frequency and Nasopharyngeal Microbiome.
    J Virol. 2023;97:e0147222.
    >> Share

  131. ALWINE JC, Casadevall A, Enquist LW, Goodrum FD, et al
    A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses.
    J Virol. 2023 Mar 10:e0036523. doi: 10.1128/jvi.00365.
    >> Share

  132. WANG X, Wang W, Wang T, Wang J, et al
    SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
    J Virol. 2023 Mar 6:e0001123. doi: 10.1128/jvi.00011.
    >> Share

  133. MOLS VC, Lamers MM, Leijten LM, Breugem TI, et al
    Intestinal Tropism of a Betacoronavirus (Merbecovirus) in Nathusius's Pipistrelle Bat (Pipistrellus nathusii), Its Natural Host.
    J Virol. 2023 Mar 1:e0009923. doi: 10.1128/jvi.00099.
    >> Share

    February 2023
  134. FROLOV I, Agback T, Palchevska O, Dominguez F, et al
    All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein.
    J Virol. 2023 Feb 27:e0186522. doi: 10.1128/jvi.01865.
    >> Share

  135. ZHANG L, Hom N, Ojha A, Lovendahl KN, et al
    Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions.
    J Virol. 2023 Feb 15:e0165022. doi: 10.1128/jvi.01650.
    >> Share

  136. CHIEN YA, Alford BK, Wasik BR, Weichert WS, et al
    Single Particle Analysis of H3N2 Influenza Entry Differentiates the Impact of the Sialic Acids (Neu5Ac and Neu5Gc) on Virus Binding and Membrane Fusion.
    J Virol. 2023 Feb 13:e0146322. doi: 10.1128/jvi.01463.
    >> Share

  137. WANG X, Wen Z, Cao H, Luo J, et al
    Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.
    J Virol. 2023 Feb 13:e0161122. doi: 10.1128/jvi.01611.
    >> Share

  138. WANG Y, Ge F, Wang J, Li H, et al
    Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
    J Virol. 2023 Feb 13:e0176422. doi: 10.1128/jvi.01764.
    >> Share

  139. AMANAT F, Clark J, Carreno JM, Strohmeier S, et al
    Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
    J Virol. 2023 Feb 13:e0166422. doi: 10.1128/jvi.01664.
    >> Share

  140. WAN Z, Zhao Z, Sang J, Jiang W, et al
    Amino Acid Variation at Hemagglutinin Position 193 Impacts the Properties of H9N2 Avian Influenza Virus.
    J Virol. 2023 Feb 7:e0137922. doi: 10.1128/jvi.01379.
    >> Share

  141. BEI C, Zhang C, Wu H, Feng H, et al
    DDX3X Is Hijacked by Snakehead Vesiculovirus Phosphoprotein To Facilitate Virus Replication via Stabilization of the Phosphoprotein.
    J Virol. 2023 Feb 6:e0003523. doi: 10.1128/jvi.00035.
    >> Share

  142. SCHINDEWOLF C, Lokugamage K, Vu MN, Johnson BA, et al
    SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
    J Virol. 2023 Feb 1:e0153222. doi: 10.1128/jvi.01532.
    >> Share

    January 2023
  143. TJARNHAGE E, Brown D, Bogen B, Andersen TK, et al
    Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza.
    J Virol. 2023 Jan 31:e0169422. doi: 10.1128/jvi.01694.
    >> Share

  144. GOODRUM F, Lowen A, Lakdawala S, Alwine J, et al
    Virology under the Microscope-a Call for Rational Discourse.
    J Virol. 2023 Jan 26:e0008923. doi: 10.1128/jvi.00089.
    >> Share

  145. GAUDINO M, Lion A, Sagne E, Nagamine B, et al
    The Activation of the RIG-I/MDA5 Signaling Pathway upon Influenza D Virus Infection Impairs the Pulmonary Proinflammatory Response Triggered by Mycoplasma bovis Superinfection.
    J Virol. 2023 Jan 24:e0142322. doi: 10.1128/jvi.01423.
    >> Share

  146. LIU MQ, Lin HF, Li J, Chen Y, et al
    A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
    J Virol. 2023 Jan 23:e0171922. doi: 10.1128/jvi.01719.
    >> Share

  147. RAJAGOPALA SV, Strickland BA, Pakala SB, Kimura KS, et al
    Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    J Virol. 2023 Jan 19:e0147822. doi: 10.1128/jvi.01478.
    >> Share

  148. MA J, Liu X, Zhou M, Chen P, et al
    A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    J Virol. 2023 Jan 18:e0168422. doi: 10.1128/jvi.01684.
    >> Share

  149. SHIWA-SUDO N, Sakai Y, Iwata-Yoshikawa N, Watanabe S, et al
    Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    J Virol. 2023 Jan 12:e0136622. doi: 10.1128/jvi.01366.
    >> Share

  150. CREAGER HM, Kieran TJ, Zeng H, Sun X, et al
    Utility of Human In Vitro Data in Risk Assessments of Influenza A Virus Using the Ferret Model.
    J Virol. 2023 Jan 5:e0153622. doi: 10.1128/jvi.01536.
    >> Share

  151. MCGINNES CULLEN L, Luo B, Wen Z, Zhang L, et al
    The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate.
    J Virol. 2023 Jan 5:e0190022. doi: 10.1128/jvi.01900.
    >> Share

    December 2022
  152. CHANG P, Lukosaityte D, Sealy JE, Rijal P, et al
    Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.
    J Virol. 2022 Dec 21:e0143122. doi: 10.1128/jvi.01431.
    >> Share

  153. GOUMA S, Furey C, Santos JJS, Parkhouse K, et al
    Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.
    J Virol. 2022 Dec 19:e0172322. doi: 10.1128/jvi.01723.
    >> Share

  154. MEADE P, Strohmeier S, Bermudez-Gonzalez MC, Garcia-Sastre A, et al
    Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity.
    J Virol. 2022 Dec 19:e0107022. doi: 10.1128/jvi.01070.
    >> Share

  155. CHEN LF, Xu WB, Xiong S, Cai JX, et al
    PIK-24 Inhibits RSV-Induced Syncytium Formation via Direct Interaction with the p85alpha Subunit of PI3K.
    J Virol. 2022;96:e0145322.
    >> Share

  156. VALIENTE L, Lopez-Arguello S, Rodriguez-Huete A, Valbuena A, et al
    Molecular Determinants of Human Rhinovirus Infection, Assembly, and Conformational Stability at Capsid Protein Interfaces.
    J Virol. 2022;96:e0084022.
    >> Share

  157. CHEN Y, Wu Y, Chen S, Zhan Q, et al
    Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
    J Virol. 2022 Dec 5:e0124522. doi: 10.1128/jvi.01245.
    >> Share

    November 2022
  158. BELSER JA, Sun X, Kieran TJ, Brock N, et al
    Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
    J Virol. 2022 Nov 30:e0140322. doi: 10.1128/jvi.01403.
    >> Share

  159. CHOI SSA, Chan HH, Chan CM, Wang X, et al
    Neuromasts and Olfactory Organs of Zebrafish Larvae Represent Possible Sites of SARS-CoV-2 Pseudovirus Host Cell Entry.
    J Virol. 2022 Nov 30:e0141822. doi: 10.1128/jvi.01418.
    >> Share

  160. LI J, Xue L, Wang J, Meng A, et al
    Activation of the Chemokine Receptor CCR1 and Preferential Recruitment of Galphai Suppress RSV Replication: Implications for Developing Novel Respiratory Syncytial Virus Treatment Strategies.
    J Virol. 2022;96:e0130922.
    >> Share

  161. STEPHENS LM, Ross KA, McLellan JS, Narasimhan B, et al
    Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model.
    J Virol. 2022;96:e0150222.
    >> Share

  162. LISTA MJ, Winstone H, Wilson HD, Dyer A, et al
    The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
    J Virol. 2022 Nov 9:e0125022. doi: 10.1128/jvi.01250.
    >> Share

  163. JAMES J, Bhat S, Walsh SK, Karunarathna TK, et al
    The Origin of Internal Genes Contributes to the Replication and Transmission Fitness of H7N9 Avian Influenza Virus.
    J Virol. 2022 Nov 7:e0129022. doi: 10.1128/jvi.01290.
    >> Share

  164. WANG X, Kerkmann L, Hetzel M, Windmann S, et al
    Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
    J Virol. 2022 Nov 7:e0113322. doi: 10.1128/jvi.01133.
    >> Share

  165. CZERKIES M, Kochanczyk M, Korwek Z, Prus W, et al
    Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
    J Virol. 2022 Nov 3:e0134122. doi: 10.1128/jvi.01341.
    >> Share

  166. MO JS, Abente EJ, Cardenas Perez M, Sutton TC, et al
    Transmission of Human Influenza A Virus in Pigs Selects for Adaptive Mutations on the HA Gene.
    J Virol. 2022 Nov 1:e0148022. doi: 10.1128/jvi.01480.
    >> Share

    October 2022
  167. SACCO MT, Bland KM, Horner SM
    WTAP Targets the METTL3 m(6)A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.
    J Virol. 2022 Oct 31:e0099722. doi: 10.1128/jvi.00997.
    >> Share

  168. GUO K, Yombo DJK, Schmit T, Wang Z, et al
    Cellular Heterogeneity and Molecular Reprogramming of the Host Response during Influenza Acute Lung Injury.
    J Virol. 2022 Oct 26:e0124622. doi: 10.1128/jvi.01246.
    >> Share

  169. PENN R, Tregoning JS, Flight KE, Baillon L, et al
    Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model.
    J Virol. 2022 Oct 13:e0117822. doi: 10.1128/jvi.01178.
    >> Share

  170. VAN ROYEN T, Sedeyn K, Moschonas GD, Toussaint W, et al
    An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25.
    J Virol. 2022;96:e0129722.
    >> Share

  171. TAN TS, Toyoda M, Ode H, Barabona G, et al
    Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike.
    J Virol. 2022 Oct 10:e0116222. doi: 10.1128/jvi.01162.
    >> Share

  172. BONIFACIO JPPL, Williams N, Garnier L, Hugues S, et al
    Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups.
    J Virol. 2022 Oct 3:e0087122. doi: 10.1128/jvi.00871.
    >> Share

    September 2022
  173. CHEN M, Wang MH, Shen XG, Liu H, et al
    Neuropilin-1 Facilitates Pseudorabies Virus Replication and Viral Glycoprotein B Promotes Its Degradation in a Furin-Dependent Manner.
    J Virol. 2022 Sep 29:e0131822. doi: 10.1128/jvi.01318.
    >> Share

  174. BIMLER L, Ronzulli SL, Song AY, Johnson SK, et al
    Correction for Bimler et al., "Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A".
    J Virol. 2022 Sep 27:e0135822. doi: 10.1128/jvi.01358.
    >> Share

  175. GUAN M, Olivier AK, Lu X, Epperson W, et al
    The Sialyl Lewis X Glycan Receptor Facilitates Infection of Subtype H7 Avian Influenza A Viruses.
    J Virol. 2022 Sep 20:e0134422. doi: 10.1128/jvi.01344.
    >> Share

  176. GELLENONCOURT S, Saunders N, Robinot R, Auguste L, et al
    The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    J Virol. 2022 Sep 19:e0130122. doi: 10.1128/jvi.01301.
    >> Share

  177. SIA ZR, Chiem K, Huang WC, Seffouh A, et al
    Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.
    J Virol. 2022 Sep 15:e0100622. doi: 10.1128/jvi.01006.
    >> Share

  178. CALIENDO V, Leijten L, van de Bildt MWG, Poen MJ, et al
    Long-Term Protective Effect of Serial Infections with H5N8 Highly Pathogenic Avian Influenza Virus in Wild Ducks.
    J Virol. 2022 Sep 13:e0123322. doi: 10.1128/jvi.01233.
    >> Share

  179. BEDI S, Mudgal R, Haag A, Ono A, et al
    A Glu-Glu-Tyr Sequence in the Cytoplasmic Tail of the M2 Protein Renders Influenza A Virus Susceptible to Restriction of the Hemagglutinin-M2 Association in Primary Human Macrophages.
    J Virol. 2022 Sep 13:e0071622. doi: 10.1128/jvi.00716.
    >> Share

  180. AO Z, Ouyang MJ, Olukitibi TA, Warner B, et al
    A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    J Virol. 2022 Sep 7:e0133722. doi: 10.1128/jvi.01337.
    >> Share

  181. EVSEEV D, Miranzo-Navarro D, Fleming-Canepa X, Webster RG, et al
    Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling.
    J Virol. 2022 Sep 7:e0077622. doi: 10.1128/jvi.00776.
    >> Share

    August 2022
  182. ZHANG C, Cui H, Guo Z, Chen Z, et al
    SARS-CoV-2 Virus Culture, Genomic and Subgenomic RNA Load, and Rapid Antigen Test in Experimentally Infected Syrian Hamsters.
    J Virol. 2022 Aug 30:e0103422. doi: 10.1128/jvi.01034.
    >> Share

  183. SHEN W, Wang Q, Wang Z, Liu M, et al
    Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
    J Virol. 2022 Aug 29:e0123822. doi: 10.1128/jvi.01238.
    >> Share

  184. FAN B, Peng Q, Song S, Shi D, et al
    Nonstructural Protein 1 of Variant PEDV Plays a Key Role in Escaping Replication Restriction by Complement C3.
    J Virol. 2022 Aug 29:e0102422. doi: 10.1128/jvi.01024.
    >> Share

  185. MARTINS M, do Nascimento GM, Nooruzzaman M, Yuan F, et al
    The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    J Virol. 2022 Aug 24:e0096122. doi: 10.1128/jvi.00961.
    >> Share

  186. SU C, He J, Han P, Bai B, et al
    Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
    J Virol. 2022 Aug 24:e0081422. doi: 10.1128/jvi.00814.
    >> Share

  187. KAZEMI S, Lopez-Munoz AD, Holly J, Jin L, et al
    Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
    J Virol. 2022 Aug 24:e0025622. doi: 10.1128/jvi.00256.
    >> Share

  188. JIAO Z, Yan Y, Chen Y, Wang G, et al
    Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
    J Virol. 2022 Aug 24:e0090722. doi: 10.1128/jvi.00907.
    >> Share

  189. NEERUKONDA SN, Wang R, Vassell R, Baha H, et al
    Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
    J Virol. 2022 Aug 24:e0114022. doi: 10.1128/jvi.01140.
    >> Share

  190. BLAUROCK C, Pfaff F, Scheibner D, Hoffmann B, et al
    Evidence for Different Virulence Determinants and Host Response after Infection of Turkeys and Chickens with Highly Pathogenic H7N1 Avian Influenza Virus.
    J Virol. 2022 Aug 22:e0099422. doi: 10.1128/jvi.00994.
    >> Share

  191. ZHOU Y, Zheng R, Liu D, Liu S, et al
    UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
    J Virol. 2022 Aug 18:e0074122. doi: 10.1128/jvi.00741.
    >> Share

  192. GUPTA SL, Mantus G, Manning KE, Ellis M, et al
    Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
    J Virol. 2022 Aug 17:e0058222. doi: 10.1128/jvi.00582.
    >> Share

  193. HAN Y, Bai X, Liu S, Zhu J, et al
    XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity.
    J Virol. 2022 Aug 16:e0077422. doi: 10.1128/jvi.00774.
    >> Share

  194. SHI J, Zheng J, Tai W, Verma AK, et al
    A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 16:e0011822. doi: 10.1128/jvi.00118.
    >> Share

  195. FARRUKEE R, Gunalan V, Maurer-Stroh S, Reading PC, et al
    Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
    J Virol. 2022;96:e0091822.
    >> Share

  196. UNDI RB, Larabee JL, Filiberti A, Ulahannan S, et al
    Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
    J Virol. 2022 Aug 9:e0096722. doi: 10.1128/jvi.00967.
    >> Share

  197. CHAN M, Tiwary M, Wu HL, Tailor N, et al
    Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques.
    J Virol. 2022 Aug 4:e0072822. doi: 10.1128/jvi.00728.
    >> Share

  198. ABDELNABI R, Foo CS, Kaptein SJF, Boudewijns R, et al
    A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 4:e0075822. doi: 10.1128/jvi.00758.
    >> Share

  199. ZHAN W, Tian X, Zhang X, Xing S, et al
    Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    J Virol. 2022 Aug 4:e0048022. doi: 10.1128/jvi.00480.
    >> Share

  200. ABBADI N, Nagashima K, Pena-Briseno A, Ross TM, et al
    Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies.
    J Virol. 2022 Aug 2:e0089622. doi: 10.1128/jvi.00896.
    >> Share

  201. SCHWAB LSU, Londrigan SL, Brooks AG, Hurt AC, et al
    Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets.
    J Virol. 2022 Aug 2:e0055922. doi: 10.1128/jvi.00559.
    >> Share

  202. XU C, Zhang N, Yang Y, Liang W, et al
    Immune Escape Adaptive Mutations in Hemagglutinin Are Responsible for the Antigenic Drift of Eurasian Avian-Like H1N1 Swine Influenza Viruses.
    J Virol. 2022 Aug 2:e0097122. doi: 10.1128/jvi.00971.
    >> Share

  203. LI Z, Fang P, Duan P, Chen J, et al
    Porcine Deltacoronavirus Infection Cleaves HDAC2 to Attenuate Its Antiviral Activity.
    J Virol. 2022 Aug 2:e0102722. doi: 10.1128/jvi.01027.
    >> Share

  204. YUAN M, Chen X, Zhu Y, Dong X, et al
    A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
    J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.
    >> Share

    July 2022
  205. FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al
    Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.
    >> Share

  206. HUI X, Cao L, Xu T, Zhao L, et al
    PSMD12-Mediated M1 Ubiquitination of Influenza A Virus at K102 Regulates Viral Replication.
    J Virol. 2022 Jul 21:e0078622. doi: 10.1128/jvi.00786.
    >> Share

  207. AKAISHI T, Horii A, Ishii T
    Sequence Exchange Involving Dozens of Consecutive Bases with External Origin in SARS-Related Coronaviruses.
    J Virol. 2022 Jul 20:e0100222. doi: 10.1128/jvi.01002.
    >> Share

  208. GUO H, Li A, Lin HF, Liu MQ, et al
    The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint.
    J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.
    >> Share

  209. KAMIKI H, Murakami S, Nishikaze T, Hiono T, et al
    Influenza A Virus Agnostic Receptor Tropism Revealed Using a Novel Biological System with Terminal Sialic Acid Knockout Cells.
    J Virol. 2022 Jul 18:e0041622. doi: 10.1128/jvi.00416.
    >> Share

  210. BEACH SS, Hull MA, Ytreberg FM, Patel JS, et al
    Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory Syncytial Virus Fusion Glycoprotein.
    J Virol. 2022;96:e0035322.
    >> Share

  211. MOYO-GWETE T, Madzivhandila M, Mkhize NN, Kgagudi P, et al
    Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
    J Virol. 2022 Jul 13:e0055822. doi: 10.1128/jvi.00558.
    >> Share

  212. CHAPARIAN RR, Harding AT, Hamele CE, Riebe K, et al
    A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
    J Virol. 2022 Jul 12:e0068922. doi: 10.1128/jvi.00689.
    >> Share

  213. OISHI K, Horiuchi S, Minkoff JM, tenOever BR, et al
    The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    J Virol. 2022 Jul 12:e0076522. doi: 10.1128/jvi.00765.
    >> Share

  214. PUSNIK J, Konig J, Mai K, Richter E, et al
    Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
    J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
    >> Share

  215. VAN DE VEN K, van Dijken H, Du W, de Heij F, et al
    Varying Viral Replication and Disease Profiles of H2N2 Influenza in Ferrets Is Associated with Virus Isolate and Inoculation Route.
    J Virol. 2022 Jul 11:e0073222. doi: 10.1128/jvi.00732.
    >> Share

  216. YOUK S, Leyson C, Killian ML, Torchetti MK, et al
    Evolution of the North American Lineage H7 Avian Influenza Viruses in Association with H7 Virus's Introduction to Poultry.
    J Virol. 2022 Jul 7:e0027822. doi: 10.1128/jvi.00278.
    >> Share

  217. HAMELE CE, Russell AB, Heaton NS
    In Vivo Profiling of Individual Multiciliated Cells during Acute Influenza A Virus Infection.
    J Virol. 2022 Jul 6:e0050522. doi: 10.1128/jvi.00505.
    >> Share

    June 2022
  218. VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
    J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.
    >> Share

  219. JIANG C, Li L, Xue M, Zhao L, et al
    Long-Term Expanding Porcine Airway Organoids Provide Insights into the Pathogenesis and Innate Immunity of Porcine Respiratory Coronavirus Infection.
    J Virol. 2022 Jun 28:e0073822. doi: 10.1128/jvi.00738.
    >> Share

  220. DIEBOLD O, Gonzalez V, Venditti L, Sharp C, et al
    Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes.
    J Virol. 2022 Jun 27:e0048822. doi: 10.1128/jvi.00488.
    >> Share

  221. BI W, Chen G, Dang B
    Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
    J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.
    >> Share

  222. CHAN CE, Ng CG, Lim AP, Seah SL, et al
    The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
    J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.
    >> Share

  223. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    >> Share

  224. SUN C, Yuan RY, Xie C, Sun JF, et al
    Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
    J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
    >> Share

  225. LAVIE M, Dubuisson J, Belouzard S
    SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
    >> Share

  226. CHRISTENSEN SR, Martin ET, Petrie JG, Monto AS, et al
    The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade.
    J Virol. 2022;96:e0220021.
    >> Share

  227. SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al
    A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
    J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
    >> Share

  228. SCHEIBNER D, Breithaupt A, Luttermann C, Blaurock C, et al
    Genetic Determinants for Virulence and Transmission of the Panzootic Avian Influenza Virus H5N8 Clade 2.3.4.4 in Pekin Ducks.
    J Virol. 2022 Jun 7:e0014922. doi: 10.1128/jvi.00149.
    >> Share

  229. CHEN X, Li J, Yang L, Zhou Y, et al
    Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
    J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
    >> Share

  230. LIU H, Bai Y, Zhang X, Gao T, et al
    SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.
    J Virol. 2022 Jun 2:e0041222. doi: 10.1128/jvi.00412.
    >> Share

    May 2022
  231. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
    Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
    J Virol. 2022 May 31:e0032022. doi: 10.1128/jvi.00320.
    >> Share

  232. ZHENG H, Ma L, Gui R, Lin X, et al
    G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2.
    J Virol. 2022 May 23:e0049422. doi: 10.1128/jvi.00494.
    >> Share

  233. VANDOORN E, Stadejek W, Parys A, Chepkwony S, et al
    Pathobiology of an NS1-Truncated H3N2 Swine Influenza Virus Strain in Pigs.
    J Virol. 2022 May 12:e0051922. doi: 10.1128/jvi.00519.
    >> Share

  234. NCHIOUA R, Schundner A, Kmiec D, Prelli Bozzo C, et al
    SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
    J Virol. 2022 May 11:e0059422. doi: 10.1128/jvi.00594.
    >> Share

    April 2022
  235. DIEFENBACHER M, Tan TJC, Bauer DLV, Stadtmueller BM, et al
    Interactions between Influenza A Virus Nucleoprotein and Gene Segment Untranslated Regions Facilitate Selective Modulation of Viral Gene Expression.
    J Virol. 2022 Apr 25:e0020522. doi: 10.1128/jvi.00205.
    >> Share

  236. ROACH SN, Fiege JK, Shepherd FK, Wiggen TD, et al
    Respiratory Influenza Virus Infection Causes Dynamic Tuft Cell and Innate Lymphoid Cell Changes in the Small Intestine.
    J Virol. 2022 Apr 21:e0035222. doi: 10.1128/jvi.00352.
    >> Share

  237. KIRKPATRICK ROUBIDOUX E, Sano K, McMahon M, Carreno JM, et al
    Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
    J Virol. 2022 Apr 21:e0033222. doi: 10.1128/jvi.00332.
    >> Share

  238. ZHENG XS, Wang Q, Min J, Shen XR, et al
    Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection.
    J Virol. 2022 Apr 14:e0003822. doi: 10.1128/jvi.00038.
    >> Share

  239. RAJAN A, Piedra FA, Aideyan L, McBride T, et al
    Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection.
    J Virol. 2022;96:e0190421.
    >> Share

  240. NUNEZ CASTREJON AM, O'Rourke SM, Kauvar LM, DuBois RM, et al
    Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens.
    J Virol. 2022;96:e0220121.
    >> Share

  241. DESCHAMBAULT Y, Lynch J, Warner B, Tierney K, et al
    Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
    >> Share

  242. BAO D, Lu C, Ma T, Xu G, et al
    Hydrophobic Residues at the Intracellular Domain of the M2 Protein Play an Important Role in Budding and Membrane Integrity of Influenza Virus.
    J Virol. 2022 Apr 11:e0037322. doi: 10.1128/jvi.00373.
    >> Share

  243. CHEN J, Li Z, Guo J, Xu S, et al
    SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
    J Virol. 2022 Apr 7:e0003722. doi: 10.1128/jvi.00037.
    >> Share

  244. FARIAS JP, da Silva PS, Fogaca MMC, Santana IVR, et al
    The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
    J Virol. 2022 Apr 7:e0017722. doi: 10.1128/jvi.00177.
    >> Share

  245. LI J, Lin C, Zhou X, Zhong F, et al
    Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
    J Virol. 2022 Apr 7:e0201321. doi: 10.1128/jvi.02013.
    >> Share

  246. KLASSE PJ, Moore JP
    Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
    J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
    >> Share

  247. LIU X, Zheng L, Wang T, Li Y, et al
    A System Based on Novel Parainfluenza Virus PIV5-L for Efficient Gene Delivery of B-Lymphoma Cells.
    J Virol. 2022 Apr 4:e0025722. doi: 10.1128/jvi.00257.
    >> Share

    March 2022
  248. HANCOCK TJ, Hickman P, Kazerooni N, Kennedy M, et al
    Possible Cross-Reactivity of Feline and White-Tailed Deer Antibodies against the SARS-CoV-2 Receptor Binding Domain.
    J Virol. 2022 Mar 30:e0025022. doi: 10.1128/jvi.00250.
    >> Share

  249. ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
    Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    J Virol. 2022 Mar 28:e0012822. doi: 10.1128/jvi.00128.
    >> Share

  250. GENG Q, Shi K, Ye G, Zhang W, et al
    Structural Basis for Human Receptor Recognition by SARS-CoV Omicron Variant BA.1.
    J Virol. 2022 Mar 28:e0024922. doi: 10.1128/jvi.00249.
    >> Share

  251. LIU MQ, Jiang RD, Guo J, Chen Y, et al
    Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
    J Virol. 2022 Mar 28:e0016922. doi: 10.1128/jvi.00169.
    >> Share

  252. XIANG J, Lu M, Shi M, Cheng X, et al
    Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
    J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
    >> Share

  253. JIANG L, Samant N, Liu P, Somasundaran M, et al
    Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
    J Virol. 2022;96:e0198221.
    >> Share

  254. LI Y, Liu S, Chen Y, Chen B, et al
    Syk Facilitates Influenza A Virus Replication by Restraining Innate Immunity at the Late Stage of Viral Infection.
    J Virol. 2022 Mar 16:e0020022. doi: 10.1128/jvi.00200.
    >> Share

  255. BERKHOUT B, Herrera-Carrillo E
    SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
    J Virol. 2022 Mar 16:e0009022. doi: 10.1128/jvi.00090.
    >> Share

  256. GAO J, Tang YD, Hu W, Zheng C, et al
    When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2.
    J Virol. 2022 Mar 16:e0013622. doi: 10.1128/jvi.00136.
    >> Share

  257. ALLEN JD, Ross TM
    Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
    J Virol. 2022 Mar 15:e0165221. doi: 10.1128/jvi.01652.
    >> Share

  258. METZ-ZUMARAN C, Kee C, Doldan P, Guo C, et al
    Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    J Virol. 2022 Mar 9:e0170521. doi: 10.1128/jvi.01705.
    >> Share

  259. HU M, Jones JC, Banoth B, Ojha CR, et al
    Swine H1N1 Influenza Virus Variants with Enhanced Polymerase Activity and HA Stability Promote Airborne Transmission in Ferrets.
    J Virol. 2022 Mar 7:e0010022. doi: 10.1128/jvi.00100.
    >> Share

    February 2022
  260. JUNG C, Kmiec D, Koepke L, Zech F, et al
    Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?
    J Virol. 2022 Feb 28:jvi0207721. doi: 10.1128/jvi.02077.
    >> Share

  261. KIM EH, Nguyen TQ, Casel MAB, Rollon R, et al
    Coinfection of SARS-CoV-2 and Influenza A virus increased disease severity, impaired neutralizing antibody, and CD4+ T cell responses.
    J Virol. 2022 Feb 2:jvi0187321. doi: 10.1128/jvi.01873.
    >> Share

  262. ROSU ME, Kok A, Bestebroer TM, de Meulder D, et al
    Contribution of neuraminidase to the efficacy of seasonal split influenza vaccines in the ferret model.
    J Virol. 2022 Feb 2:jvi0195921. doi: 10.1128/jvi.01959.
    >> Share

  263. ARIUMI Y
    Host cellular RNA helicases regulate SARS-CoV-2 infection.
    J Virol. 2022 Feb 2:jvi0000222. doi: 10.1128/jvi.00002.
    >> Share

    January 2022
  264. MURER L, Petkidis A, Vallet T, Vignuzzi M, et al
    Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
    J Virol. 2022;96:e0106021.
    >> Share

  265. LIU S, Chou CK, Wu WW, Luan B, et al
    Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
    J Virol. 2022 Jan 26:jvi0221621. doi: 10.1128/jvi.02216.
    >> Share

  266. WONG TY, Horspool AM, Russ BP, Ye C, et al
    Evaluating antibody mediated protection against Alpha, Beta, and Delta SARS-CoV-2 variants of concern in K18-hACE2 transgenic mice.
    J Virol. 2022 Jan 26:jvi0218421. doi: 10.1128/jvi.02184.
    >> Share

  267. SPRUIT CM, Zhu X, Tomris I, Carrasco MR, et al
    N-glycolylneuraminic acid binding of avian and equine H7 influenza A viruses.
    J Virol. 2022 Jan 19:jvi0212021. doi: 10.1128/jvi.02120.
    >> Share

  268. BANERJEE S, De A, Kedia N, Bhakta K, et al
    The species-specific 282 residue in the PB2 subunit of the polymerase regulates RNA synthesis and replication of influenza A viruses infecting bat and non-bat hosts.
    J Virol. 2022 Jan 19:jvi0219021. doi: 10.1128/jvi.02190.
    >> Share

  269. MIYAMOTO S, Muramoto Y, Shindo K, Fujita-Fujiharu Y, et al
    Contribution of RNA-RNA interactions mediated by the genome packaging signals for the selective genome packaging of influenza A virus.
    J Virol. 2022 Jan 19:JVI0164121. doi: 10.1128/JVI.01641.
    >> Share

  270. DU S, Xu W, Wang Y, Li L, et al
    The "LLQY" motif on SARS-CoV-2 spike protein affects S incorporation into virus particles.
    J Virol. 2022 Jan 19:jvi0189721. doi: 10.1128/jvi.01897.
    >> Share

  271. TANG B, Sun EZ, Zhang ZL, Liu SL, et al
    Sphingomyelin-Sequestered Cholesterol Domain Recruits Formin-Binding Protein 17 for Constricting Clathrin-Coated Pits in Influenza Virus Entry.
    J Virol. 2022 Jan 12:JVI0181321. doi: 10.1128/JVI.01813.
    >> Share

  272. BHAT S, James J, Sadeyen JR, Mahmood S, et al
    Co-infection of chickens with H9N2 and H7N9 avian influenza viruses leads to emergence of reassortant H9N9 virus with increased fitness for poultry and a zoonotic potential.
    J Virol. 2022 Jan 12:jvi0185621. doi: 10.1128/jvi.01856.
    >> Share

  273. VELER H, Fan H, Keown J, Sharps J, et al
    The C-terminal domains of the PB2 subunit of the influenza A virus RNA polymerase directly interact with cellular GTPase Rab11a.
    J Virol. 2022 Jan 12:jvi0197921. doi: 10.1128/jvi.01979.
    >> Share

  274. RASHID MU, Gao A, Coombs KM
    Influenza A virus uses PSMA2 for downregulation of NRF2-mediated oxidative stress response.
    J Virol. 2022 Jan 12:jvi0199021. doi: 10.1128/jvi.01990.
    >> Share


  275. Articles of Significant Interest in This Issue.
    J Virol. 2022;96:e0186421.
    >> Share

  276. CHAUDHRY MZ, Eschke K, Hoffmann M, Grashoff M, et al
    Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    J Virol. 2022 Jan 12:jvi0218621. doi: 10.1128/jvi.02186.
    >> Share

  277. KIMBLE JB, Wymore Brand M, Kaplan BS, Gauger P, et al
    Vaccine-associated enhanced respiratory disease following influenza virus infection in ferrets recapitulates the model in pigs.
    J Virol. 2022 Jan 5:JVI0172521. doi: 10.1128/JVI.01725.
    >> Share

    December 2021
  278. HUANG Y, Skarlupka AL, Jang H, Blas-Machado U, et al
    SARS-CoV-2 and Influenza A virus Co-infections in Ferrets.
    J Virol. 2021 Dec 22:JVI0179121. doi: 10.1128/JVI.01791.
    >> Share

  279. NILSSON-PAYANT BE, tenOever BR, Te Velthuis AJW
    The host factor ANP32A is required for influenza A virus vRNA and cRNA synthesis.
    J Virol. 2021 Dec 22:jvi0209221. doi: 10.1128/jvi.02092.
    >> Share

  280. OLIVARRIA GM, Cheng Y, Furman S, Pachow C, et al
    Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
    J Virol. 2021 Dec 22:jvi0196921. doi: 10.1128/jvi.01969.
    >> Share

  281. ETTICH J, Werner J, Weitz HT, Mueller E, et al
    A hybrid soluble gp130/spike-nanobody fusion protein simultaneously blocks IL-6 trans-signaling and cellular infection with SARS-CoV2.
    J Virol. 2021 Dec 22:JVI0162221. doi: 10.1128/JVI.01622.
    >> Share

  282. GUO J, Chen J, Li Y, Li Y, et al
    SUMOylation of matrix protein M1 and filamentous morphology collectively contribute to the replication and virulence of highly pathogenic H5N1 avian influenza viruses in mammals.
    J Virol. 2021 Dec 15:JVI0163021. doi: 10.1128/JVI.01630.
    >> Share

  283. CAO K, Wang X, Peng H, Ding L, et al
    A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
    J Virol. 2021 Dec 15:JVI0157821. doi: 10.1128/JVI.01578.
    >> Share

  284. NELSON M, O'Brien LM, Davies C, Keyser E, et al
    Comparison of experimental MERS-CoV infection acquired by three individual routes of infection in the common marmoset.
    J Virol. 2021 Dec 15:JVI0173921. doi: 10.1128/JVI.01739.
    >> Share

  285. SAKA N, Matsumoto Y, Ohta K, Kolakofsky D, et al
    A point mutation in human parainfluenza virus type 2 nucleoprotein leads to two separate effects on virus replication.
    J Virol. 2021 Dec 8:JVI0206721. doi: 10.1128/JVI.02067.
    >> Share

  286. ZHANG Y, Yan Q, Luo K, He P, et al
    Analysis of B cell receptor repertoires reveals key signatures of systemic B cell response after SARS-CoV-2 infection.
    J Virol. 2021 Dec 8:JVI0160021. doi: 10.1128/JVI.01600.
    >> Share

  287. MALICOAT J, Manivasagam S, Zuniga S, Sola I, et al
    Development of a Single-cycle Infectious SARS-CoV-2 Virus Replicon Particle System for use in BSL2 Laboratories.
    J Virol. 2021 Dec 1:JVI0183721. doi: 10.1128/JVI.01837.
    >> Share

    November 2021
  288. ZHANG S, Go EP, Ding H, Anang S, et al
    Glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
    J Virol. 2021 Nov 24:JVI0162621. doi: 10.1128/JVI.01626.
    >> Share

  289. MARTINS M, Fernandes MHV, Joshi LR, Diel DG, et al
    Age-related susceptibility of ferrets to SARS-CoV-2 infection.
    J Virol. 2021 Nov 24:JVI0145521. doi: 10.1128/JVI.01455.
    >> Share

  290. BURCKHARDT RM, Dennehy JJ, Poon LLM, Saif LJ, et al
    Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
    J Virol. 2021 Nov 24:JVI0197321. doi: 10.1128/JVI.01973.
    >> Share

  291. TAKAMATSU Y, Imai M, Maeda K, Nakajima N, et al
    Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
    J Virol. 2021 Nov 24:JVI0155121. doi: 10.1128/JVI.01551.
    >> Share

  292. ZHANG H, Zheng H, Guo P, Hu L, et al
    Correction for Zhang et al., "Broadly Protective CD8(+) T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine".
    J Virol. 2021;95:e0175021.
    >> Share

  293. LIU Y, Wang B, Liang QZ, Shi FS, et al
    Roles of Two Major Domains of the Porcine Deltacoronavirus S1 Subunit in Receptor Binding and Neutralization.
    J Virol. 2021;95:e0111821.
    >> Share

  294. DANIELS RS, Galiano M, Ermetal B, Kwong J, et al
    Temporal and gene reassortment analysis of influenza C outbreaks in Hong Kong SAR, China.
    J Virol. 2021 Nov 17:JVI0192821. doi: 10.1128/JVI.01928.
    >> Share

  295. CHAI H, Li X, Li M, Lv X, et al
    Emergence, Evolution, and Pathogenicity of Influenza A(H7N4) Virus in Shorebirds, China.
    J Virol. 2021 Nov 17:JVI0171721. doi: 10.1128/JVI.01717.
    >> Share

  296. SOUZA CK, Anderson TK, Chang J, Venkatesh D, et al
    Antigenic distance between North American swine and human seasonal H3N2 influenza A viruses as an indication of zoonotic risk to humans.
    J Virol. 2021 Nov 10:JVI0137421. doi: 10.1128/JVI.01374.
    >> Share

  297. BASU A, Penumutchu S, Nguyen K, Mbonye U, et al
    A structurally conserved RNA element within SARS-CoV-2 ORF1a RNA and S mRNA regulates translation in response to viral S protein-induced signaling in human lung cells.
    J Virol. 2021 Nov 10:JVI0167821. doi: 10.1128/JVI.01678.
    >> Share

  298. DONG X, Wang X, Xie M, Wu W, et al
    Structural Basis of Human Parainfluenza Virus 3 Unassembled Nucleoprotein in Complex with Its Viral ChaperoneHPIV3 Nucleoprotein-Phosphoprotein Structure.
    J Virol. 2021 Nov 3:JVI0164821. doi: 10.1128/JVI.01648.
    >> Share

  299. LAMARCA AP, de Almeida LGP, da Silva Francisco Junior R, Cavalcante L, et al
    Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil.
    J Virol. 2021 Nov 3:JVI0122821. doi: 10.1128/JVI.01228.
    >> Share

    October 2021
  300. DESCAMPS D, Peres de Oliveira A, Gonnin L, Madrieres S, et al
    Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
    J Virol. 2021;95:e0091221.
    >> Share

  301. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Reply to Grigoriev et al., "Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs 1 of Non-coding RNA?"
    J Virol. 2021 Oct 27:JVI0169021. doi: 10.1128/JVI.01690.
    >> Share

  302. YU J, Collins ND, Mercado NB, McMahan K, et al
    Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
    J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
    >> Share

  303. GRIGORIEV A, Kelley JJ, Guan L
    Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs of Non-coding RNA?
    J Virol. 2021 Oct 27:JVI0146221. doi: 10.1128/JVI.01462.
    >> Share

  304. TAN J, O'Dell G, Hernandez MM, Sordillo EM, et al
    Human anti-neuraminidase antibodies reduce airborne transmission of clinical influenza virus isolates in the guinea pig model.
    J Virol. 2021 Oct 20:JVI0142121. doi: 10.1128/JVI.01421.
    >> Share

  305. WINKLER ES, Chen RE, Alam F, Yildiz S, et al
    SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice.
    J Virol. 2021 Oct 20:JVI0151121. doi: 10.1128/JVI.01511.
    >> Share

  306. DONG W, Mead H, Tian L, Park JG, et al
    The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus.
    J Virol. 2021 Oct 20:JVI0096421. doi: 10.1128/JVI.00964.
    >> Share

  307. REN W, Zhu Y, Lan J, Chen H, et al
    Susceptibilities of human ACE2 genetic variants in coronavirus infection.
    J Virol. 2021 Oct 20:JVI0149221. doi: 10.1128/JVI.01492.
    >> Share

  308. SIDDIQ MM, Chan AT, Miorin L, Yadaw AS, et al
    Functional Effects of Cardiomyocyte Injury in COVID-19.
    J Virol. 2021 Oct 20:JVI0106321. doi: 10.1128/JVI.01063.
    >> Share

  309. GAO Q, Yang C, Ren C, Zhang S, et al
    Correction for Gao et al., "Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus".
    J Virol. 2021;95:e0141321.
    >> Share

  310. GAO J, Klenow L, Parsons L, Malik T, et al
    Design of the Recombinant Influenza Neuraminidase Antigen is Crucial for its Biochemical Properties and Protective Efficacy.
    J Virol. 2021 Oct 6:JVI0116021. doi: 10.1128/JVI.01160.
    >> Share

  311. BESSIERE P, Figueroa T, Coggon A, Foret-Lucas C, et al
    Opposite outcomes of the within-host competition between highly and low pathogenic H5N8 avian influenza viruses in chickens compared to ducks.
    J Virol. 2021 Oct 6:JVI0136621. doi: 10.1128/JVI.01366.
    >> Share

  312. NAVARATNARAJAH CK, Pease DR, Halfmann P, Taye B, et al
    Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition.
    J Virol. 2021 Oct 6:JVI0136821. doi: 10.1128/JVI.01368.
    >> Share

    September 2021
  313. SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
    Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
    J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
    >> Share

  314. SHUE B, Chiramel AI, Cerikan B, To TH, et al
    Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication.
    J Virol. 2021 Sep 29:JVI0059621. doi: 10.1128/JVI.00596.
    >> Share

  315. KIM YJ, Witwit H, Cubitt B, de la Torre JC, et al
    Inhibitors of anti-apoptotic Bcl-2 family proteins exhibit potent and broad-spectrum anti-mammarenavirus activity via cell cycle arrest at G0/G1 phase.
    J Virol. 2021 Sep 29:JVI0139921. doi: 10.1128/JVI.01399.
    >> Share

  316. TANG W, Li Y, Song Q, Wang Z, et al
    Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.
    J Virol. 2021;95:e0120521.
    >> Share

  317. PELZ L, Rudiger D, Dogra T, Alnaji FG, et al
    Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy.
    J Virol. 2021 Sep 22:JVI0117421. doi: 10.1128/JVI.01174.
    >> Share

  318. QIAN Y, Lei T, Patel PS, Lee CH, et al
    Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin.
    J Virol. 2021 Sep 22:JVI0139621. doi: 10.1128/JVI.01396.
    >> Share

  319. CHOI A, Koch M, Wu K, Dixon G, et al
    Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
    J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
    >> Share

  320. ACHARYA A, Pandey K, Thurman M, Klug E, et al
    Discovery and evaluation of entry inhibitors for SARS-CoV-2 and its emerging variants.
    J Virol. 2021 Sep 22:JVI0143721. doi: 10.1128/JVI.01437.
    >> Share

  321. SHANG C, Zhuang X, Zhang H, Li Y, et al
    Inhibition of autophagy suppresses SARS-CoV-2 replication and ameliorates pneumonia in hACE2 transgenic mice and xenografted human lung tissues.
    J Virol. 2021 Sep 22:JVI0153721. doi: 10.1128/JVI.01537.
    >> Share

  322. KIRCHENBAUM GA, Sautto GA, Richardson RA, Ecker JW, et al
    A competitive hemagglutination inhibition assay for dissecting functional antibody activity to influenza virus.
    J Virol. 2021 Sep 15:JVI0237920. doi: 10.1128/JVI.02379.
    >> Share

  323. TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
    Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
    >> Share

  324. NILSSON-PAYANT BE, Uhl S, Grimont A, Doane AS, et al
    The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication.
    J Virol. 2021 Sep 15:JVI0125721. doi: 10.1128/JVI.01257.
    >> Share

  325. CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
    A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
    J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
    >> Share

  326. ABRAHAM M, Beavis AC, Xiao P, Villinger FJ, et al
    Evaluation of a new viral vaccine vector in mice and rhesus macaques: J paramyxovirus (JPV)-expressing HA of influenza A virus H5N1.
    J Virol. 2021 Sep 1:JVI0132121. doi: 10.1128/JVI.01321.
    >> Share

  327. WILLIAMS CM, Roy S, Califano D, McKenzie ANJ, et al
    IL-33-ILC2 axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine.
    J Virol. 2021 Sep 1:JVI0059821. doi: 10.1128/JVI.00598.
    >> Share

    August 2021
  328. XUN G, Song X, Hu J, Zhang H, et al
    Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
    J Virol. 2021;95:e0048521.
    >> Share

  329. SATO K, Hayashi H, Shimotai Y, Yamaya M, et al
    TMPRSS2 activates hemagglutinin-esterase glycoprotein of influenza C virus.
    J Virol. 2021 Aug 18:JVI0129621. doi: 10.1128/JVI.01296.
    >> Share

  330. KREUTZBERGER AJB, Sanyal A, Ojha R, Pyle JD, et al
    Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
    J Virol. 2021 Aug 18:JVI0097521. doi: 10.1128/JVI.00975.
    >> Share

  331. KAPLAN BS, Anderson TK, Chang J, Santos J, et al
    Evolution and antigenic advancement of N2 neuraminidase of swine influenza A viruses circulating in the United States following two separate introductions from human seasonal viruses.
    J Virol. 2021 Aug 11:JVI0063221. doi: 10.1128/JVI.00632.
    >> Share

  332. KAWAI A, Yamamoto Y, Nogimori T, Takeshita K, et al
    The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses.
    J Virol. 2021 Aug 11:JVI0118021. doi: 10.1128/JVI.01180.
    >> Share

  333. TAM EH, Liu YC, Woung CH, Liu HM, et al
    Role of the chaperone protein 14-3-3epsilon in the regulation of influenza A virus-activated beta interferon.
    J Virol. 2021 Aug 11:JVI0023121. doi: 10.1128/JVI.00231.
    >> Share

  334. LU M, Zhang Y, Dravid P, Li A, et al
    A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
    J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
    >> Share

    July 2021
  335. DEL SARTO J, Gerlt V, Friedrich ME, Anhlan D, et al
    Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection.
    J Virol. 2021 Jul 28:JVI0067221. doi: 10.1128/JVI.00672.
    >> Share

  336. BESTLE D, Limburg H, Kruhl D, Harbig A, et al
    Hemagglutinins of avian influenza viruses are proteolytically activated by TMPRSS2 in human and murine airway cells.
    J Virol. 2021 Jul 28:JVI0090621. doi: 10.1128/JVI.00906.
    >> Share

  337. CANTWELL AM, Singh H, Platt M, Yu Y, et al
    Kinetic multi-omic analysis of responses to SARS-CoV-2 infection in a model of severe COVID-19.
    J Virol. 2021 Jul 28:JVI0101021. doi: 10.1128/JVI.01010.
    >> Share

  338. RAHMAN K, Compton AA
    The indirect antiviral potential of long non-coding RNAs encoded by IFITM pseudogenes.
    J Virol. 2021 Jul 28:JVI0068021. doi: 10.1128/JVI.00680.
    >> Share

  339. GREEN G, Johnson SM, Costello H, Brakel K, et al
    CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
    J Virol. 2021;95:e0001021.
    >> Share

  340. YANG J, Zhang P, Huang M, Qiao S, et al
    Key amino acids of M1-41 and M2-27 determine growth and pathogenicity of chimeric H17 bat influenza virus in cells and in mice.
    J Virol. 2021 Jul 21:JVI0101921. doi: 10.1128/JVI.01019.
    >> Share

  341. LI Z, Gao F, Lan Y, Guan J, et al
    Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent of ULK1.
    J Virol. 2021 Jul 21:JVI0085121. doi: 10.1128/JVI.00851.
    >> Share

  342. FERRARI M, Mekkaoui L, Ilca FT, Akbar Z, et al
    Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
    J Virol. 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
    >> Share

  343. CHEN DY, Khan N, Close BJ, Goel RK, et al
    SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.
    J Virol. 2021 Jul 14:JVI0086221. doi: 10.1128/JVI.00862.
    >> Share

  344. LAI KK, Cheung NN, Yang F, Dai J, et al
    Correction for Lai et al., "Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics".
    J Virol. 2021;95:e0066521.
    >> Share

  345. LIANG W, Zhang Y, Li M, Al-Shaebi F, et al
    Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.
    J Virol. 2021;95:e0056321.
    >> Share

  346. LEYSON CM, Youk S, Ferreira HL, Suarez DL, et al
    Multiple gene segments are associated with enhanced virulence of clade 2.3.4.4 H5N8 highly pathogenic avian influenza virus in mallards.
    J Virol. 2021 Jul 7:JVI0095521. doi: 10.1128/JVI.00955.
    >> Share

    June 2021
  347. YU J, Huang C, Sheng Z, Wang Z, et al
    Identification of One Critical Amino Acid Residue of the Nucleoprotein as a Determinant for in vitro Viral Replication Fitness of Influenza D Virus.
    J Virol. 2021 Jun 30:JVI0097121. doi: 10.1128/JVI.00971.
    >> Share

  348. XIAO Y, Zhang W, Pan M, Bauer DLV, et al
    A synergistic effect between 3' terminal noncoding and adjacent coding regions of influenza A virus HA segment on template preference.
    J Virol. 2021 Jun 30:JVI0087821. doi: 10.1128/JVI.00878.
    >> Share

  349. NGUYEN HT, Falzarano D, Gerdts V, Liu Q, et al
    Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.
    J Virol. 2021 Jun 30:JVI0068721. doi: 10.1128/JVI.00687.
    >> Share

  350. BLAUROCK C, Breithaupt A, Scheibner D, Bagato O, et al
    Preferential selection and contribution of non-structural protein 1 (NS1) to the efficient transmission of the panzootic avian influenza H5N8 2.3.4.4 clades A and B viruses in chickens and ducks.
    J Virol. 2021 Jun 23:JVI0044521. doi: 10.1128/JVI.00445.
    >> Share

  351. SKARLUPKA AL, Bebin-Blackwell AG, Sumner SF, Ross TM, et al
    Universal influenza virus neuraminidase vaccine elicits protective immune responses against human seasonal and pre-pandemic strains.
    J Virol. 2021 Jun 23:JVI0075921. doi: 10.1128/JVI.00759.
    >> Share

  352. SUN G, Sui Y, Zhou Y, Ya J, et al
    Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.
    J Virol. 2021 Jun 23:JVI0086121. doi: 10.1128/JVI.00861.
    >> Share

  353. KUMAR A, Ishida R, Strilets T, Cole J, et al
    SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    J Virol. 2021;95:e0026621.
    >> Share

  354. WANG X, Zhao Y, Yan F, Wang T, et al
    Viral and host transcriptomes in SARS-CoV-2 infected human lung cells.
    J Virol. 2021 Jun 9:JVI0060021. doi: 10.1128/JVI.00600.
    >> Share

  355. NELSON SA, Dileepan T, Rasley A, Jenkins MK, et al
    Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza antigen that are sufficient to mediate protection from influenza virus challenge.
    J Virol. 2021 Jun 2:JVI0084121. doi: 10.1128/JVI.00841.
    >> Share

  356. OU J, Zhou Z, Dai R, Zhang J, et al
    V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
    J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
    >> Share

    May 2021
  357. LIU H, Plancarte M, Ball EE, Weiss CM, et al
    Respiratory tract explant infection dynamics of influenza A virus in California sea lions, northern elephant seals, and rhesus macaques.
    J Virol. 2021 May 26:JVI0040321. doi: 10.1128/JVI.00403.
    >> Share

  358. BAKRE A, Jones L, Murray J, Reneer ZB, et al
    Innate antiviral cytokine response to swine influenza virus by swine respiratory epithelial cells.
    J Virol. 2021 May 12. pii: JVI.00692-21. doi: 10.1128/JVI.00692.
    >> Share

  359. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
    J Virol. 2021 May 12. pii: JVI.00294-21. doi: 10.1128/JVI.00294.
    >> Share

  360. LULLA V, Wandel MP, Bandyra KJ, Ulferts R, et al
    Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome.
    J Virol. 2021 May 7. pii: JVI.00663-21. doi: 10.1128/JVI.00663.
    >> Share

  361. TRIBOLET L, Alexander MR, Brice AM, van Vuren PJ, et al
    ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
    J Virol. 2021 May 7. pii: JVI.00327-21. doi: 10.1128/JVI.00327.
    >> Share

  362. LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
    CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
    >> Share

  363. HORMAN WSJ, Kedzierska K, Rootes CL, Bean AGD, et al
    Upregulated expression of ferret Interferon-Inducible Transmembrane genes by IFN-alpha and influenza virus infection.
    J Virol. 2021 May 5. pii: JVI.00111-21. doi: 10.1128/JVI.00111.
    >> Share

    April 2021
  364. RESNICK SJ, Iketani S, Hong SJ, Zask A, et al
    Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity.
    J Virol. 2021 Apr 28. pii: JVI.02374-20. doi: 10.1128/JVI.02374.
    >> Share

  365. ALFI O, Yakirevitch A, Wald O, Wandel O, et al
    Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract.
    J Virol. 2021 Apr 23. pii: JVI.00130-21. doi: 10.1128/JVI.00130.
    >> Share

  366. VIDAL SJ, Collier AY, Yu J, McMahan K, et al
    Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
    J Virol. 2021 Apr 23. pii: JVI.00404-21. doi: 10.1128/JVI.00404.
    >> Share

  367. SAUTTO GA, Ecker JW, Ross TM
    An H1N1 Computationally Optimized Broadly Reactive Antigen elicits a neutralizing antibody response against an emerging human-infecting Eurasian avian-like swine influenza virus.
    J Virol. 2021 Apr 14. pii: JVI.02421-20. doi: 10.1128/JVI.02421.
    >> Share

  368. CHIEM K, Lopez-Garcia D, Ortego J, Martinez-Sobrido L, et al
    Identification of amino acid residues required for inhibition of host gene expression by influenza A/Viet Nam/1203/2004 H5N1 PA-X.
    J Virol. 2021 Apr 14. pii: JVI.00408-21. doi: 10.1128/JVI.00408.
    >> Share

  369. NILSSON-PAYANT BE, Blanco-Melo D, Uhl S, Escudero-Perez B, et al
    Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.
    J Virol. 2021;95.
    >> Share

  370. MORI K, Ohniwa RL, Takizawa N, Naito T, et al
    Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain using an Engineered High-Fidelity Viral Polymerase.
    J Virol. 2021 Apr 7. pii: JVI.00493-21. doi: 10.1128/JVI.00493.
    >> Share

  371. ZHENG J, Wen L, Yen HL, Liu M, et al
    Phenotypic and functional characteristics of a novel influenza hemagglutinin-specific memory NK cell.
    J Virol. 2021 Apr 7. pii: JVI.00165-21. doi: 10.1128/JVI.00165.
    >> Share

  372. ZHANG H, Zheng H, Guo P, Hu L, et al
    Broadly protective CD8(+) T cell immunity to highly conserved epitopes elicited by heat shock protein gp96-adjuvanted influenza monovalent split vaccine.
    J Virol. 2021 Apr 7. pii: JVI.00507-21. doi: 10.1128/JVI.00507.
    >> Share

  373. PATEL DR, Field CJ, Septer KM, Sim DG, et al
    Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
    J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
    >> Share

    March 2021
  374. WANG J, Shu T, Deng W, Zheng Y, et al
    Mucosal priming with a recombinant influenza A virus-vectored vaccine elicits T-cell and antibody responses to HIV-1 in mice.
    J Virol. 2021 Mar 31. pii: JVI.00059-21. doi: 10.1128/JVI.00059.
    >> Share

  375. LIU W, Reyes HM, Yang JF, Li Y, et al
    Activation of STING signaling pathway effectively blocks human coronavirus infection.
    J Virol. 2021 Mar 31. pii: JVI.00490-21. doi: 10.1128/JVI.00490.
    >> Share

  376. TOMITA Y, Matsuyama S, Fukuhara H, Maenaka K, et al
    The physiological TMPRSS2 inhibitor HAI-2 alleviates SARS-CoV-2 infection.
    J Virol. 2021 Mar 31. pii: JVI.00434-21. doi: 10.1128/JVI.00434.
    >> Share

  377. SLAINE PD, Kleer M, Duguay BA, Pringle ES, et al
    Thiopurines activate an antiviral unfolded protein response that blocks influenza A virus glycoprotein accumulation.
    J Virol. 2021 Mar 24. pii: JVI.00453-21. doi: 10.1128/JVI.00453.
    >> Share

  378. DANZY S, Lowen AC, Steel J
    A quantitative approach to assess influenza A virus fitness and transmission in guinea pigs.
    J Virol. 2021 Mar 17. pii: JVI.02320-20. doi: 10.1128/JVI.02320.
    >> Share

  379. PU J, Yin Y, Liu J, Wang X, et al
    Reassortment with dominant chicken H9N2 influenza virus contributed to the fifth H7N9 virus human epidemic.
    J Virol. 2021 Mar 17. pii: JVI.01578-20. doi: 10.1128/JVI.01578.
    >> Share

  380. YANG H, Winkler W, Wu X
    Interferon Inducer IFI35 regulates RIG-I-mediated innate antiviral response through mutual antagonism with Influenza protein NS1.
    J Virol. 2021 Mar 10. pii: JVI.00283-21. doi: 10.1128/JVI.00283.
    >> Share

  381. PENG J, Ran Y, Xie H, Deng L, et al
    Sarco/Endoplasmic Reticulum Ca(2+) Transporting ATPase (SERCA) Modulates Autophagic, Inflammatory, and Mitochondrial Responses during Influenza A Virus Infection in Human Lung Cells.
    J Virol. 2021 Mar 10. pii: JVI.00217-21. doi: 10.1128/JVI.00217.
    >> Share

  382. GONG W, He X, Huang K, Zhang Y, et al
    Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly.
    J Virol. 2021 Mar 3. pii: JVI.00008-21. doi: 10.1128/JVI.00008.
    >> Share

  383. PHAN T, Fay EJ, Lee Z, Aron S, et al
    Segment-specific kinetics of mRNA, cRNA and vRNA accumulation during influenza infection.
    J Virol. 2021 Mar 3. pii: JVI.02102-20. doi: 10.1128/JVI.02102.
    >> Share

  384. LUO Z, Girton AW, Heaton BE, Heaton NS, et al
    Engineered influenza virions reveal the contributions of non-hemagglutinin structural proteins to vaccine mediated protection.
    J Virol. 2021 Mar 3. pii: JVI.02021-20. doi: 10.1128/JVI.02021.
    >> Share

    February 2021
  385. JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
    Correction for Jeong et al., "In Vitro Profiling of Laninamivir-Resistant Substitutions in N3 to N9 Avian Influenza Virus Neuraminidase Subtypes and Their Association with In Vivo Susceptibility".
    J Virol. 2021;95.
    >> Share

  386. YANG F, Pang B, Lai KK, Cheung NN, et al
    Discovery of a novel specific inhibitor targeting influenza A nucleoprotein with pleiotropic inhibitory effects on various steps of viral life cycle.
    J Virol. 2021 Feb 24. pii: JVI.01432-20. doi: 10.1128/JVI.01432.
    >> Share

  387. DHAKAL S, Loube J, Misplon JA, Lo CY, et al
    Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
    J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
    >> Share

  388. HOYE BJ, Donato CM, Lisovski S, Deng YM, et al
    Reassortment and persistence of influenza A viruses from diverse geographic origins within Australian wild birds: evidence from a small, isolated population of Ruddy turnstones.
    J Virol. 2021 Feb 24. pii: JVI.02193-20. doi: 10.1128/JVI.02193.
    >> Share

  389. BINJAWADAGI B, Ma Y, Binjawadagi R, Brakel K, et al
    Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    J Virol. 2021;95.
    >> Share

  390. HORNICH BF, Grosskopf AK, Schlagowski S, Tenbusch M, et al
    SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation.
    J Virol. 2021 Feb 19. pii: JVI.00002-21. doi: 10.1128/JVI.00002.
    >> Share

  391. ORR-BURKS N, Murray J, Todd KV, Bakre A, et al
    GPCR and ion channel genes used by influenza virus for replication.
    J Virol. 2021 Feb 3. pii: JVI.02410-20. doi: 10.1128/JVI.02410.
    >> Share

    January 2021
  392. LEVENE RE, Shrestha SD, Gaglia MM
    The influenza A virus host shutoff factor PA-X is rapidly turned over in a strain-specific manner.
    J Virol. 2021 Jan 27. pii: JVI.02312-20. doi: 10.1128/JVI.02312.
    >> Share

  393. ZHANG X, Pu J, Sun Y, Yuhai B, et al
    Neurovirulence of avian influenza virus is dependent on the interaction of viral NP protein with host factor FMRP in the murine brain.
    J Virol. 2021 Jan 6. pii: JVI.01272-20. doi: 10.1128/JVI.01272.
    >> Share

  394. PATIL A, Anhlan D, Ferrando V, Mecate-Zambrano A, et al
    Phosphorylation of influenza A virus NS1 at serine 205 mediates its viral polymerase-enhancing function.
    J Virol. 2021 Jan 6. pii: JVI.02369-20. doi: 10.1128/JVI.02369.
    >> Share

  395. FENG M, Zhang Q, Wu W, Chen L, et al
    Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus Replication by Suppressing Innate Immunity via NF-kappaB and JAK-STAT Signaling Pathways.
    J Virol. 2021 Jan 6. pii: JVI.02038-20. doi: 10.1128/JVI.02038.
    >> Share

  396. OHTA K, Saka N, Nishio M
    Human parainfluenza virus type 2 V protein modulates iron homeostasis.
    J Virol. 2021 Jan 6. pii: JVI.01861-20. doi: 10.1128/JVI.01861.
    >> Share

    December 2020
  397. WANG Q, Pan W, Wang S, Pan C, et al
    Protein tyrosine phosphatase SHP2 suppresses host innate immunity against influenza A virus through regulating EGFR-mediated signaling.
    J Virol. 2020 Dec 23. pii: JVI.02001-20. doi: 10.1128/JVI.02001.
    >> Share

  398. VERHAGEN JH, Eriksson P, Leijten L, Blixt O, et al
    Host range of influenza A virus H1 to H16 in Eurasian ducks based on tissue and receptor binding studies.
    J Virol. 2020 Dec 23. pii: JVI.01873-20. doi: 10.1128/JVI.01873.
    >> Share

  399. HUMAN S, Hotard AL, Rostad CA, Lee S, et al
    A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
    J Virol. 2020;95.
    >> Share

  400. LEE E, Sandgren K, Duette G, Stylianou VV, et al
    Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity.
    J Virol. 2020 Dec 21. pii: JVI.02002-20. doi: 10.1128/JVI.02002.
    >> Share

  401. YOUK SS, Leyson CM, Seibert BA, Jadhao S, et al
    Mutations in PB1, NP, HA, and NA Contribute to Increased Virus Fitness of H5N2 Highly Pathogenic Avian Influenza Virus Clade 2.3.4.4 in Chickens.
    J Virol. 2020 Dec 2. pii: JVI.01675-20. doi: 10.1128/JVI.01675.
    >> Share

  402. BIMLER L, Ronzulli SL, Song AY, Johnson SK, et al
    Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A.
    J Virol. 2020 Dec 2. pii: JVI.01027-20. doi: 10.1128/JVI.01027.
    >> Share

  403. EVERETT HE, van Diemen PM, Aramouni M, Ramsay A, et al
    Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated Pigs.
    J Virol. 2020 Dec 2. pii: JVI.01787-20. doi: 10.1128/JVI.01787.
    >> Share

  404. PEACOCK TP, Sealy JE, Harvey WT, Benton DJ, et al
    Genetic determinants of receptor-binding preference and zoonotic potential of H9N2 avian influenza viruses.
    J Virol. 2020 Dec 2. pii: JVI.01651-20. doi: 10.1128/JVI.01651.
    >> Share

    November 2020
  405. PAHMEIER F, Neufeldt CJ, Cerikan B, Prasad V, et al
    A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
    J Virol. 2020 Nov 30. pii: JVI.01715-20. doi: 10.1128/JVI.01715.
    >> Share

  406. CLARK LK, Green TJ, Petit CM
    Structure of nonstructural protein 1 from SARS-CoV-2.
    J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
    >> Share

  407. MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
    HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
    >> Share

  408. MA N, Li X, Jiang H, Dai Y, et al
    Influenza neuraminidase engages CD83 and promotes pulmonary injury.
    J Virol. 2020 Nov 11. pii: JVI.01753-20. doi: 10.1128/JVI.01753.
    >> Share

  409. BAO D, Xue R, Zhang M, Lu C, et al
    N-linked glycosylation plays an important role in budding of NA protein and virulence of influenza viruses.
    J Virol. 2020 Nov 11. pii: JVI.02042-20. doi: 10.1128/JVI.02042.
    >> Share

  410. TIAN X, Landreth S, Lu Y, Pandey K, et al
    A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    J Virol. 2020 Nov 11. pii: JVI.02154-20. doi: 10.1128/JVI.02154.
    >> Share

  411. JENKINS T, Wang R, Harder O, Xue M, et al
    A novel live attenuated RSV vaccine candidate with mutations in the L protein SAM binding site and the G protein cleavage site is protective in cotton rats and a rhesus macaque.
    J Virol. 2020 Nov 11. pii: JVI.01568-20. doi: 10.1128/JVI.01568.
    >> Share

  412. FENWICK C, Croxatto A, Coste AT, Pojer F, et al
    Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
    >> Share

    October 2020
  413. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    >> Share

  414. LIANG B, Matsuoka Y, Le Nouen C, Liu X, et al
    A parainfluenza virus vector expressing the respiratory syncytial virus (RSV) prefusion F protein is more effective than RSV for boosting a primary immunization with RSV.
    J Virol. 2020 Oct 28. pii: JVI.01512-20. doi: 10.1128/JVI.01512.
    >> Share

  415. GHORBANI A, Abundo MC, Ji H, Taylor KJM, et al
    Viral Subpopulation Screening Guides in Designing a High Interferon Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
    J Virol. 2020 Oct 28. pii: JVI.01722-20. doi: 10.1128/JVI.01722.
    >> Share

  416. COOK PW, Stark T, Jones J, Kondor R, et al
    Detection and Characterization of Swine-origin Influenza A(H1N1) Pandemic 2009 Viruses in Humans Following Zoonotic Transmission.
    J Virol. 2020 Oct 28. pii: JVI.01066-20. doi: 10.1128/JVI.01066.
    >> Share

  417. RENEER ZB, Jamieson PJ, Skarlupka AL, Huang Y, et al
    Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    J Virol. 2020 Oct 28. pii: JVI.01526-20. doi: 10.1128/JVI.01526.
    >> Share

  418. JOBE F, Simpson J, Hawes P, Guzman E, et al
    Respiratory Syncytial Virus Sequesters NF-kappaB Subunit p65 to Cytoplasmic Inclusion Bodies To Inhibit Innate Immune Signaling.
    J Virol. 2020;94.
    >> Share

  419. GAO Q, Yang C, Ren C, Zhang S, et al
    Eukaryotic translation elongation factor 1 delta inhibits the nuclear import of nucleoprotein and PA-PB1 heterodimer of influenza A virus.
    J Virol. 2020 Oct 21. pii: JVI.01391-20. doi: 10.1128/JVI.01391.
    >> Share

  420. MANZOOR R, Eguchi N, Yoshida R, Ozaki H, et al
    A novel mechanism underlying antiviral activity of an influenza virus M2-specific antibody.
    J Virol. 2020 Oct 14. pii: JVI.01277-20. doi: 10.1128/JVI.01277.
    >> Share

  421. JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
    In vitro profiling of laninamivir-resistant substitutions in N3 to N9 avian influenza neuraminidase subtypes and their association with in vivo susceptibility.
    J Virol. 2020 Oct 14. pii: JVI.01679-20. doi: 10.1128/JVI.01679.
    >> Share

  422. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    >> Share

  423. LI Z, Qu X, Liu X, Huan C, et al
    GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
    J Virol. 2020;94.
    >> Share

  424. ARAI Y, Kawashita N, Elgendy EM, Ibrahim MS, et al
    PA mutations inherited during viral evolution act cooperatively to increase replication of contemporary H5N1 influenza virus with an expanded host range.
    J Virol. 2020 Oct 7. pii: JVI.01582-20. doi: 10.1128/JVI.01582.
    >> Share

  425. WEI Y, Zeng Y, Zhang X, Xu S, et al
    The Nucleoprotein of H7N9 Influenza Virus Positively Regulates TRAF3-Mediated Innate Signaling and Attenuates Viral Virulence in Mice.
    J Virol. 2020 Oct 7. pii: JVI.01640-20. doi: 10.1128/JVI.01640.
    >> Share

    September 2020
  426. CRIADO MF, Sa E Silva M, Lee DH, de Lima Salge CA, et al
    Cross-protection by inactivated H5 pre-pandemic vaccine seed strains against diverse Goose/Guangdong lineage H5N1 highly pathogenic avian influenza viruses.
    J Virol. 2020 Sep 30. pii: JVI.00720-20. doi: 10.1128/JVI.00720.
    >> Share

  427. NELSON MI, Perofsky A, McBride DS, Rambo-Martin BL, et al
    A heterogenous swine show circuit drives zoonotic transmission of influenza A viruses in the United States.
    J Virol. 2020 Sep 30. pii: JVI.01453-20. doi: 10.1128/JVI.01453.
    >> Share

  428. XUE M, Wang R, Harder O, Chen P, et al
    Stable attenuation of human respiratory syncytial virus for live vaccines by deletion and insertion of amino acids in the hinge region between the mRNA capping and methyltransferase domains of the large polymerase protein.
    J Virol. 2020 Sep 30. pii: JVI.01831-20. doi: 10.1128/JVI.01831.
    >> Share

  429. KINDER JT, Moncman CL, Barrett C, Jin H, et al
    Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
    J Virol. 2020;94.
    >> Share

  430. BROCATO RL, Principe LM, Kim RK, Zeng X, et al
    Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
    J Virol. 2020 Sep 8. pii: JVI.01683-20. doi: 10.1128/JVI.01683.
    >> Share

    August 2020
  431. BUSSE DC, Habgood-Coote D, Clare S, Brandt C, et al
    Interferon-Induced Protein 44 and Interferon-Induced Protein 44-Like Restrict Replication of Respiratory Syncytial Virus.
    J Virol. 2020;94.
    >> Share

  432. FROGGATT HM, Heaton BE, Heaton NS
    Development of a fluorescence based, high-throughput SARS-CoV-2 3CL(pro) reporter assay.
    J Virol. 2020 Aug 25. pii: JVI.01265-20. doi: 10.1128/JVI.01265.
    >> Share

  433. WESTON S, Coleman CM, Haupt R, Logue J, et al
    Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo.
    J Virol. 2020 Aug 19. pii: JVI.01218-20. doi: 10.1128/JVI.01218.
    >> Share

  434. JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
    Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
    J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
    >> Share

    July 2020
  435. KAPLAN BS, Kimble JB, Chang J, Anderson TK, et al
    Aerosol Transmission from Infected Swine to Ferrets of an H3N2 Virus Collected from an Agricultural Fair and Associated with Human Variant Infections.
    J Virol. 2020;94.
    >> Share

  436. VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
    Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
    >> Share

    June 2020
  437. GHAFARI M, Lumby CK, Weissman DB, Illingworth CJR, et al
    Inferring Transmission Bottleneck Size from Viral Sequence Data Using a Novel Haplotype Reconstruction Method.
    J Virol. 2020;94.
    >> Share

  438. DENG Y, Herbert JA, Robinson E, Ren L, et al
    Neutrophil-Airway Epithelial Interactions Result in Increased Epithelial Damage and Viral Clearance during Respiratory Syncytial Virus Infection.
    J Virol. 2020;94.
    >> Share

    May 2020
  439. LI J, Li M, Wang X, Sun M, et al
    Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.
    J Virol. 2020;94.
    >> Share

    April 2020
  440. YANG J, Ma C, Zhao Y, Fan A, et al
    Hepatitis B virus core particles containing a conserved region of the G protein combined with interleukin-35 protected mice against respiratory syncytial virus infection without vaccine-enhanced immunopathology.
    J Virol. 2020 Apr 22. pii: JVI.00007-20. doi: 10.1128/JVI.00007.
    >> Share

  441. KANDASAMY M, Furlong K, Perez JT, Manicassamy S, et al
    Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.
    J Virol. 2020;94.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016